Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
11 participants
INTERVENTIONAL
2009-09-30
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores
NCT06293755
BCT-HA Kit for Dehydrated and Wrinkled Skin
NCT05514834
Clinical Application of Patented Lyophilized PLT in Acne Scar Repairment.
NCT04829370
To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture
NCT06404372
Device for Improving Skin Quality and Texture on the Face and Neck
NCT06645366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
PoreSkin, a human acellular dermal matrix, were used for scar contracture treatment
PoreSkin
a human acellular dermal matrix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PoreSkin
a human acellular dermal matrix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-60 years with burn scar contracture and hypertrophic scar
Exclusion Criteria
* Immunocompromise host (DM, HIV infected)
* Evidence of malnutrition
* Active malignancy
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Apichai Angspatt
Apichai Angspatt
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
283/52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.